Patents by Inventor Seul Ki MEANG

Seul Ki MEANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration
    Patent number: 11266658
    Abstract: The present disclosure relates to an orally administered pharmaceutical formulation containing an inclusion complex formed as varenicline or a pharmaceutically acceptable salt thereof is included in cyclodextrin. The pharmaceutical formulation can improve convenience of medication by effectively masking the bitter taste of the drug and the irritation during swallowing, can provide the oxidation stability of varenicline and can improve the solubility of the drug.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: March 8, 2022
    Assignee: CTC BIO, INC.
    Inventors: Hong Ryeol Jeon, Do-Woo Kwon, Bong-Sang Lee, Seul Ki Meang, Su-Jun Park, Seong-Shin Kwak
  • TASTE-MASKED AND ORALLY ADMINISTERED PHARMACEUTICAL PREPARATION CONTAINING VARENICLINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20200276113
    Abstract: The present disclosure relates to a pharmaceutical preparation having varenicline or a pharmaceutically acceptable salt thereof as an active ingredient. More particularly, it relates to an orally administered pharmaceutical preparation which allows limited use of a sweetening agent or a flavoring agent by effectively masking the unique taste of varenicline, particularly bitterness, which is a bitter and burning taste, and ensures convenience in taking the pharmaceutical preparation by being orally administrable without irritation, while containing a pharmaceutically effective amount of varenicline or a pharmaceutically acceptable salt thereof, and a method for preparing the same.
    Type: Application
    Filed: January 9, 2017
    Publication date: September 3, 2020
    Applicants: CTC BIO, INC., CTC BIO, INC.
    Inventors: Hong Ryeol JEON, Bong-Sang LEE, Su-Jun PARK, Jiyeong HAN, Myeongcheol KIL, Min Seop KIM, Seul Ki MEANG
  • PREPARATION, COMPRISING INCLUSION COMPLEX OF VARENICLINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR ORAL ADMINISTRATION
    Publication number: 20200061078
    Abstract: The present disclosure relates to an orally administered pharmaceutical formulation containing an inclusion complex formed as varenicline or a pharmaceutically acceptable salt thereof is included in cyclodextrin. The pharmaceutical formulation can improve convenience of medication by effectively masking the bitter taste of the drug and the irritation during swallowing, can provide the oxidation stability of varenicline and can improve the solubility of the drug.
    Type: Application
    Filed: March 2, 2018
    Publication date: February 27, 2020
    Inventors: Hong Ryeol JEON, Do-Woo KWON, Bong-Sang LEE, Seul Ki MEANG, Su-Jun PARK, Seong-Shin KWAK